These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 31330079)

  • 41. Synthesis of novel (R)-4-fluorophenyl-1H-1,2,3-triazoles: A new class of α-glucosidase inhibitors.
    Avula SK; Khan A; Halim SA; Al-Abri Z; Anwar MU; Al-Rawahi A; Csuk R; Al-Harrasi A
    Bioorg Chem; 2019 Oct; 91():103182. PubMed ID: 31404793
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis, biological activities, and molecular docking studies of triazolo[4,3-b]triazine derivatives as a novel class of α-glucosidase and α-amylase inhibitors.
    Seyfi S; Salarinejad S; Moghimi S; Toolabi M; Sadeghian N; Tüzün B; Firoozpour L; Ketabforoosh SHME; Taslimi P; Foroumadi A
    Arch Pharm (Weinheim); 2024 Jul; 357(7):e2300628. PubMed ID: 38501879
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro and in silico evaluations of diarylpentanoid series as α-glucosidase inhibitor.
    Leong SW; Abas F; Lam KW; Yusoff K
    Bioorg Med Chem Lett; 2018 Feb; 28(3):302-309. PubMed ID: 29292226
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis, in vitro evaluation and molecular docking studies of biscoumarin thiourea as a new inhibitor of α-glucosidases.
    Zawawi NK; Taha M; Ahmat N; Ismail NH; Wadood A; Rahim F; Rehman AU
    Bioorg Chem; 2015 Dec; 63():36-44. PubMed ID: 26432614
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New carbazole linked 1,2,3-triazoles as highly potent non-sugar α-glucosidase inhibitors.
    Iqbal S; Khan MA; Javaid K; Sadiq R; Fazal-Ur-Rehman S; Choudhary MI; Basha FZ
    Bioorg Chem; 2017 Oct; 74():72-81. PubMed ID: 28756277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Flavone-1,2,3-triazole derivatives as potential α-glucosidase inhibitors: Synthesis, enzyme inhibition, kinetic analysis and molecular docking study.
    Dhameja M; Kumar H; Kurella S; Uma A; Gupta P
    Bioorg Chem; 2022 Oct; 127():106028. PubMed ID: 35868105
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis, in vitro evaluation and molecular docking studies of novel amide linked triazolyl glycoconjugates as new inhibitors of α-glucosidase.
    Gupta SJ; Dutta S; Gajbhiye RL; Jaisankar P; Sen AK
    Bioorg Chem; 2017 Jun; 72():11-20. PubMed ID: 28346871
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Triazoloquinazolines as a new class of potent α-glucosidase inhibitors: in vitro evaluation and docking study.
    Abuelizz HA; Anouar EH; Ahmad R; Azman NIIN; Marzouk M; Al-Salahi R
    PLoS One; 2019; 14(8):e0220379. PubMed ID: 31412050
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis, molecular docking and α-glucosidase inhibition of 5-aryl-2-(6'-nitrobenzofuran-2'-yl)-1,3,4-oxadiazoles.
    Taha M; Ismail NH; Imran S; Wadood A; Rahim F; Saad SM; Khan KM; Nasir A
    Bioorg Chem; 2016 Jun; 66():117-23. PubMed ID: 27149363
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyanoacetohydrazide linked to 1,2,3-triazole derivatives: a new class of α-glucosidase inhibitors.
    Iraji A; Shareghi-Brojeni D; Mojtabavi S; Faramarzi MA; Akbarzadeh T; Saeedi M
    Sci Rep; 2022 May; 12(1):8647. PubMed ID: 35606520
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis, Biological Evaluation and Molecular Docking Study of 2-Substituted-4,6-Diarylpyrimidines as α-Glucosidase Inhibitors.
    Gong Z; Xie Z; Qiu J; Wang G
    Molecules; 2017 Oct; 22(11):. PubMed ID: 29084182
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis, in vitro α-glucosidase inhibitory activity and docking studies of novel chromone-isatin derivatives.
    Wang G; Chen M; Qiu J; Xie Z; Cao A
    Bioorg Med Chem Lett; 2018 Jan; 28(2):113-116. PubMed ID: 29208524
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation and molecular modelling of bis-Schiff base derivatives as potential leads for management of diabetes mellitus.
    Daoud S; Thiab S; Jazzazi TMA; Al-Shboul TMA; Ullah S
    Acta Pharm; 2022 Sep; 72(3):449-458. PubMed ID: 36651543
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Celebrex derivatives: Synthesis, α-glucosidase inhibition, crystal structures and molecular docking studies.
    Kausar N; Ullah S; Khan MA; Zafar H; Atia-Tul-Wahab ; Choudhary MI; Yousuf S
    Bioorg Chem; 2021 Jan; 106():104499. PubMed ID: 33288319
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design, synthesis and antidiabetic study of triazole clubbed indole derivatives as α-glucosidase inhibitors.
    Ritu ; Sharma P; Gupta GD; Asati V
    Bioorg Chem; 2023 Oct; 139():106750. PubMed ID: 37499530
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis of indole-based-thiadiazole derivatives as a potent inhibitor of α-glucosidase enzyme along with in silico study.
    Alomari M; Taha M; Rahim F; Selvaraj M; Iqbal N; Chigurupati S; Hussain S; Uddin N; Almandil NB; Nawaz M; Khalid Farooq R; Khan KM
    Bioorg Chem; 2021 Mar; 108():104638. PubMed ID: 33508679
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quinazolinone-dihydropyrano[3,2-b]pyran hybrids as new α-glucosidase inhibitors: Design, synthesis, enzymatic inhibition, docking study and prediction of pharmacokinetic.
    Sherafati M; Mirzazadeh R; Barzegari E; Mohammadi-Khanaposhtani M; Azizian H; Sadegh Asgari M; Hosseini S; Zabihi E; Mojtabavi S; Ali Faramarzi M; Mahdavi M; Larijani B; Rastegar H; Hamedifar H; Hamed Hajimiri M
    Bioorg Chem; 2021 Apr; 109():104703. PubMed ID: 33609917
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel Coumarin Containing Dithiocarbamate Derivatives as Potent α-Glucosidase Inhibitors for Management of Type 2 Diabetes.
    Mollazadeh M; Mohammadi-Khanaposhtani M; Valizadeh Y; Zonouzi A; Faramarzi MA; Kiani M; Biglar M; Larijani B; Hamedifar H; Mahdavi M; Hajimiri MH
    Med Chem; 2021; 17(3):264-272. PubMed ID: 32851964
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A simple and efficient synthesis of novel inhibitors of alpha-glucosidase based on benzimidazole skeleton and molecular docking studies.
    Özil M; Emirik M; Etlik SY; Ülker S; Kahveci B
    Bioorg Chem; 2016 Oct; 68():226-35. PubMed ID: 27572707
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design, synthesis, in vitro, and in silico evaluations of benzo[d]imidazole-amide-1,2,3-triazole-N-arylacetamide hybrids as new antidiabetic agents targeting α-glucosidase.
    Yousefnejad F; Mohammadi-Moghadam-Goozali M; Sayahi MH; Halimi M; Moazzam A; Mohammadi-Khanaposhtani M; Mojtabavi S; Asadi M; Faramarzi MA; Larijani B; Amanlou M; Mahdavi M
    Sci Rep; 2023 Jul; 13(1):12397. PubMed ID: 37524733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.